APO Research
Talk to an analyst

APO RESEARCH · REPORT

Vaccine Microneedle Patches

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Vaccine Microneedle Patches Market Outlook and Growth Opportunities 2026

25 December 2025192 pages

Choose your research edition.

Industry ResearchVaccine Microneedle Patches Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Vaccine Microneedle Patches Industry Growth and Trends Forecast to 203297 pages · $3,450 USDMarket StructureGlobal Vaccine Microneedle Patches Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Vaccine Microneedle Patches Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Vaccine Microneedle Patches Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Vaccine Microneedle Patches market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Vaccine Microneedle Patches is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Vaccine Microneedle Patches is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Vaccine Microneedle Patches is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Vaccine Microneedle Patches market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Vaccine Microneedle Patches market include CosMED Pharmaceutical, Micron Biomedical, Raphas, VaxessTechnologies, Shenzhen Qinglan Biotechnology, WCC Biomedical and Zhuhai Youwe Biotechnology, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Vaccine Microneedle Patches market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Vaccine Microneedle Patches and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Vaccine Microneedle Patches sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Vaccine Microneedle Patches market size, projected growth trends, production technologies, key applications, and end-use industries.

Vaccine Microneedle Patches Segment by Company

CosMED Pharmaceutical

Micron Biomedical

Raphas

VaxessTechnologies

Shenzhen Qinglan Biotechnology

WCC Biomedical

Zhuhai Youwe Biotechnology

Vaccine Microneedle Patches Segment by Type

Polymers Material

Silicon Material

Others

Vaccine Microneedle Patches Segment by Application

COVID-19 Vaccine

Enterovirus 71 Vaccine

Other Vaccines

Vaccine Microneedle Patches Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Vaccine Microneedle Patches status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Vaccine Microneedle Patches market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Vaccine Microneedle Patches significant trends, drivers, influence factors in global and regions.

6. To analyze Vaccine Microneedle Patches competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Vaccine Microneedle Patches market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Vaccine Microneedle Patches and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Vaccine Microneedle Patches.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Vaccine Microneedle Patches market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Vaccine Microneedle Patches industry.

Chapter 3: Detailed analysis of Vaccine Microneedle Patches manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Vaccine Microneedle Patches in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Vaccine Microneedle Patches in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Vaccine Microneedle Patches Industry Trends Table 2. Vaccine Microneedle Patches Industry Drivers Table 3. Vaccine Microneedle Patches Industry Opportunities and Challenges Table 4. Vaccine Microneedle Patches Industry Restraints Table 5. Global Vaccine Microneedle Patches Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Vaccine Microneedle Patches Revenue Share by Company (2021-2026) Table 7. Global Vaccine Microneedle Patches Sales Volume by Company (K Pcs) & (2021-2026) Table 8. Global Vaccine Microneedle Patches Sales Volume Share by Company (2021-2026) Table 9. Global Vaccine Microneedle Patches Average Price (US$/Pc) of Company (2021-2026) Table 10. Global Vaccine Microneedle Patches Company Ranking, (2024-2026) & (USD Million) Table 11. Global Vaccine Microneedle Patches Key Company Manufacturing Base & Headquarters Table 12. Global Vaccine Microneedle Patches Company, Product Type & Application Table 13. Global Vaccine Microneedle Patches Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Vaccine Microneedle Patches by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Polymers Material Table 18. Significant Companies of Silicon Material Table 19. Significant Companies of Others Table 20. Global Vaccine Microneedle Patches Sales Volume by Type 2021 VS 2025 VS 2032 (K Pcs) Table 21. Global Vaccine Microneedle Patches Sales Volume by Type (2021-2026) & (K Pcs) Table 22. Global Vaccine Microneedle Patches Sales Volume by Type (2027-2032) & (K Pcs) Table 23. Global Vaccine Microneedle Patches Sales Volume Share by Type (2021-2026) Table 24. Global Vaccine Microneedle Patches Sales Volume Share by Type (2027-2032) Table 25. Global Vaccine Microneedle Patches Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Vaccine Microneedle Patches Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Vaccine Microneedle Patches Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Vaccine Microneedle Patches Sales Value Share by Type (2021-2026) Table 29. Global Vaccine Microneedle Patches Sales Value Share by Type (2027-2032) Table 30. Significant Companies of COVID-19 Vaccine Table 31. Significant Companies of Enterovirus 71 Vaccine Table 32. Significant Companies of Other Vaccines Table 33. Global Vaccine Microneedle Patches Sales Volume by Application 2021 VS 2025 VS 2032 (K Pcs) Table 34. Global Vaccine Microneedle Patches Sales Volume by Application (2021-2026) & (K Pcs) Table 35. Global Vaccine Microneedle Patches Sales Volume by Application (2027-2032) & (K Pcs) Table 36. Global Vaccine Microneedle Patches Sales Volume Share by Application (2021-2026) Table 37. Global Vaccine Microneedle Patches Sales Volume Share by Application (2027-2032) Table 38. Global Vaccine Microneedle Patches Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Vaccine Microneedle Patches Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Vaccine Microneedle Patches Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Vaccine Microneedle Patches Sales Value Share by Application (2021-2026) Table 42. Global Vaccine Microneedle Patches Sales Value Share by Application (2027-2032) Table 43. Global Vaccine Microneedle Patches Sales by Region: 2021 VS 2025 VS 2032 (K Pcs) Table 44. Global Vaccine Microneedle Patches Sales by Region (2021-2026) & (K Pcs) Table 45. Global Vaccine Microneedle Patches Sales Market Share by Region (2021-2026) Table 46. Global Vaccine Microneedle Patches Sales by Region (2027-2032) & (K Pcs) Table 47. Global Vaccine Microneedle Patches Sales Market Share by Region (2027-2032) Table 48. Global Vaccine Microneedle Patches Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Vaccine Microneedle Patches Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Vaccine Microneedle Patches Sales Value Share by Region (2021-2026) Table 51. Global Vaccine Microneedle Patches Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Vaccine Microneedle Patches Sales Value Share by Region (2027-2032) Table 53. Global Vaccine Microneedle Patches Market Average Price (US$/Pc) by Region (2021-2026) Table 54. Global Vaccine Microneedle Patches Market Average Price (US$/Pc) by Region (2027-2032) Table 55. Global Vaccine Microneedle Patches Sales by Country: 2021 VS 2025 VS 2032 (K Pcs) Table 56. Global Vaccine Microneedle Patches Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Vaccine Microneedle Patches Sales by Country (2021-2026) & (K Pcs) Table 58. Global Vaccine Microneedle Patches Sales Market Share by Country (2021-2026) Table 59. Global Vaccine Microneedle Patches Sales by Country (2027-2032) & (K Pcs) Table 60. Global Vaccine Microneedle Patches Sales Market Share by Country (2027-2032) Table 61. Global Vaccine Microneedle Patches Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Vaccine Microneedle Patches Sales Value Market Share by Country (2021-2026) Table 63. Global Vaccine Microneedle Patches Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Vaccine Microneedle Patches Sales Value Market Share by Country (2027-2032) Table 65. CosMED Pharmaceutical Company Information Table 66. CosMED Pharmaceutical Business Overview Table 67. CosMED Pharmaceutical Vaccine Microneedle Patches Sales (K Pcs), Value (US$ Million), Price (US$/Pc) and Gross Margin (2021-2026) Table 68. CosMED Pharmaceutical Vaccine Microneedle Patches Product Portfolio Table 69. CosMED Pharmaceutical Recent Development Table 70. Micron Biomedical Company Information Table 71. Micron Biomedical Business Overview Table 72. Micron Biomedical Vaccine Microneedle Patches Sales (K Pcs), Value (US$ Million), Price (US$/Pc) and Gross Margin (2021-2026) Table 73. Micron Biomedical Vaccine Microneedle Patches Product Portfolio Table 74. Micron Biomedical Recent Development Table 75. Raphas Company Information Table 76. Raphas Business Overview Table 77. Raphas Vaccine Microneedle Patches Sales (K Pcs), Value (US$ Million), Price (US$/Pc) and Gross Margin (2021-2026) Table 78. Raphas Vaccine Microneedle Patches Product Portfolio Table 79. Raphas Recent Development Table 80. VaxessTechnologies Company Information Table 81. VaxessTechnologies Business Overview Table 82. VaxessTechnologies Vaccine Microneedle Patches Sales (K Pcs), Value (US$ Million), Price (US$/Pc) and Gross Margin (2021-2026) Table 83. VaxessTechnologies Vaccine Microneedle Patches Product Portfolio Table 84. VaxessTechnologies Recent Development Table 85. Shenzhen Qinglan Biotechnology Company Information Table 86. Shenzhen Qinglan Biotechnology Business Overview Table 87. Shenzhen Qinglan Biotechnology Vaccine Microneedle Patches Sales (K Pcs), Value (US$ Million), Price (US$/Pc) and Gross Margin (2021-2026) Table 88. Shenzhen Qinglan Biotechnology Vaccine Microneedle Patches Product Portfolio Table 89. Shenzhen Qinglan Biotechnology Recent Development Table 90. WCC Biomedical Company Information Table 91. WCC Biomedical Business Overview Table 92. WCC Biomedical Vaccine Microneedle Patches Sales (K Pcs), Value (US$ Million), Price (US$/Pc) and Gross Margin (2021-2026) Table 93. WCC Biomedical Vaccine Microneedle Patches Product Portfolio Table 94. WCC Biomedical Recent Development Table 95. Zhuhai Youwe Biotechnology Company Information Table 96. Zhuhai Youwe Biotechnology Business Overview Table 97. Zhuhai Youwe Biotechnology Vaccine Microneedle Patches Sales (K Pcs), Value (US$ Million), Price (US$/Pc) and Gross Margin (2021-2026) Table 98. Zhuhai Youwe Biotechnology Vaccine Microneedle Patches Product Portfolio Table 99. Zhuhai Youwe Biotechnology Recent Development Table 100. Key Raw Materials Table 101. Raw Materials Key Suppliers Table 102. Vaccine Microneedle Patches Distributors List Table 103. Vaccine Microneedle Patches Customers List Table 104. Research Programs/Design for This Report Table 105. Authors List of This Report Table 106. Secondary Sources Table 107. Primary Sources List of Figures Figure 1. Vaccine Microneedle Patches Product Image Figure 2. Global Vaccine Microneedle Patches Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Vaccine Microneedle Patches Sales Value (2021-2032) & (US$ Million) Figure 4. Global Vaccine Microneedle Patches Sales (2021-2032) & (K Pcs) Figure 5. Global Vaccine Microneedle Patches Sales Average Price (US$/Pc) & (2021-2032) Figure 6. Global Vaccine Microneedle Patches Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Polymers Material Image Figure 10. Silicon Material Image Figure 11. Others Image Figure 12. Global Vaccine Microneedle Patches Sales Volume by Type (2021 VS 2025 VS 2032) & (K Pcs) Figure 13. Global Vaccine Microneedle Patches Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Vaccine Microneedle Patches Sales Volume Share by Type (2021-2032) Figure 15. Global Vaccine Microneedle Patches Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Vaccine Microneedle Patches Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Vaccine Microneedle Patches Sales Value Share by Type (2021-2032) Figure 18. COVID-19 Vaccine Image Figure 19. Enterovirus 71 Vaccine Image Figure 20. Other Vaccines Image Figure 21. Global Vaccine Microneedle Patches Sales Volume by Application (2021 VS 2025 VS 2032) & (K Pcs) Figure 22. Global Vaccine Microneedle Patches Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Vaccine Microneedle Patches Sales Volume Share by Application (2021-2032) Figure 24. Global Vaccine Microneedle Patches Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Vaccine Microneedle Patches Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Vaccine Microneedle Patches Sales Value Share by Application (2021-2032) Figure 27. Global Vaccine Microneedle Patches Sales by Region: 2021 VS 2025 VS 2032 (K Pcs) Figure 28. Global Vaccine Microneedle Patches Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Vaccine Microneedle Patches Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Vaccine Microneedle Patches Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Vaccine Microneedle Patches Sales Value (2021-2032) & (US$ Million) Figure 32. North America Vaccine Microneedle Patches Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Vaccine Microneedle Patches Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Vaccine Microneedle Patches Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Vaccine Microneedle Patches Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Vaccine Microneedle Patches Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Vaccine Microneedle Patches Sales Value (2021-2032) & (US$ Million) Figure 38. South America Vaccine Microneedle Patches Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Vaccine Microneedle Patches Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Vaccine Microneedle Patches Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Vaccine Microneedle Patches Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Vaccine Microneedle Patches Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Vaccine Microneedle Patches Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Vaccine Microneedle Patches Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Vaccine Microneedle Patches Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Vaccine Microneedle Patches Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Vaccine Microneedle Patches Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Vaccine Microneedle Patches Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Vaccine Microneedle Patches Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Vaccine Microneedle Patches Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Vaccine Microneedle Patches Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Vaccine Microneedle Patches Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Vaccine Microneedle Patches Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Vaccine Microneedle Patches Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Vaccine Microneedle Patches Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Vaccine Microneedle Patches Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Vaccine Microneedle Patches Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Vaccine Microneedle Patches Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Vaccine Microneedle Patches Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Vaccine Microneedle Patches Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Vaccine Microneedle Patches Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Vaccine Microneedle Patches Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Vaccine Microneedle Patches Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Vaccine Microneedle Patches Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Vaccine Microneedle Patches Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Vaccine Microneedle Patches Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Vaccine Microneedle Patches Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Vaccine Microneedle Patches Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Vaccine Microneedle Patches Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Vaccine Microneedle Patches Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Vaccine Microneedle Patches Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Vaccine Microneedle Patches Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Vaccine Microneedle Patches Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Vaccine Microneedle Patches Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Vaccine Microneedle Patches Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Vaccine Microneedle Patches Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Vaccine Microneedle Patches Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Vaccine Microneedle Patches Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Vaccine Microneedle Patches Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Vaccine Microneedle Patches Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Vaccine Microneedle Patches Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Vaccine Microneedle Patches Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Vaccine Microneedle Patches Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Vaccine Microneedle Patches Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Vaccine Microneedle Patches Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Vaccine Microneedle Patches Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Vaccine Microneedle Patches Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Vaccine Microneedle Patches Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Vaccine Microneedle Patches Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Vaccine Microneedle Patches Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Vaccine Microneedle Patches Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Vaccine Microneedle Patches Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Vaccine Microneedle Patches Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Vaccine Microneedle Patches Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Vaccine Microneedle Patches Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Vaccine Microneedle Patches Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Vaccine Microneedle Patches Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Vaccine Microneedle Patches Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Vaccine Microneedle Patches Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Vaccine Microneedle Patches Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Vaccine Microneedle Patches Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Vaccine Microneedle Patches Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Vaccine Microneedle Patches Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Vaccine Microneedle Patches Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Vaccine Microneedle Patches Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Vaccine Microneedle Patches Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Vaccine Microneedle Patches Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Vaccine Microneedle Patches Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Vaccine Microneedle Patches Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Vaccine Microneedle Patches Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Vaccine Microneedle Patches Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Vaccine Microneedle Patches Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Vaccine Microneedle Patches Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Vaccine Microneedle Patches Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Vaccine Microneedle Patches Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Vaccine Microneedle Patches Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Vaccine Microneedle Patches Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Vaccine Microneedle Patches Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Vaccine Microneedle Patches Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Vaccine Microneedle Patches Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Vaccine Microneedle Patches Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Vaccine Microneedle Patches Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Vaccine Microneedle Patches Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Vaccine Microneedle Patches Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Vaccine Microneedle Patches Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Vaccine Microneedle Patches Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Polymers Material
  • Silicon Material
  • Others
Applications
  • COVID-19 Vaccine
  • Enterovirus 71 Vaccine
  • Other Vaccines
Companies covered
  • CosMED Pharmaceutical
  • Micron Biomedical
  • Raphas
  • VaxessTechnologies
  • Shenzhen Qinglan Biotechnology
  • WCC Biomedical
  • Zhuhai Youwe Biotechnology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Vaccine Microneedle Patches Sales Value (2021-2032)
  4. 1.2.2 Global Vaccine Microneedle Patches Sales Volume (2021-2032)
  5. 1.2.3 Global Vaccine Microneedle Patches Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Vaccine Microneedle Patches Market Dynamics
  1. 2.1 Vaccine Microneedle Patches Industry Trends
  2. 2.2 Vaccine Microneedle Patches Industry Drivers
  3. 2.3 Vaccine Microneedle Patches Industry Opportunities and Challenges
  4. 2.4 Vaccine Microneedle Patches Industry Restraints
3 Vaccine Microneedle Patches Market by Company
  1. 3.1 Global Vaccine Microneedle Patches Company Revenue Ranking in 2025
  2. 3.2 Global Vaccine Microneedle Patches Revenue by Company (2021-2026)
  3. 3.3 Global Vaccine Microneedle Patches Sales Volume by Company (2021-2026)
  4. 3.4 Global Vaccine Microneedle Patches Average Price by Company (2021-2026)
  5. 3.5 Global Vaccine Microneedle Patches Company Ranking (2024-2026)
  6. 3.6 Global Vaccine Microneedle Patches Company Manufacturing Base and Headquarters
  7. 3.7 Global Vaccine Microneedle Patches Company Product Type and Application
  8. 3.8 Global Vaccine Microneedle Patches Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Vaccine Microneedle Patches Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Vaccine Microneedle Patches Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Vaccine Microneedle Patches Market by Type
  1. 4.1 Vaccine Microneedle Patches Type Introduction
  2. 4.1.1 Polymers Material
  3. 4.1.2 Silicon Material
  4. 4.1.3 Others
  5. 4.2 Global Vaccine Microneedle Patches Sales Volume by Type
  6. 4.2.1 Global Vaccine Microneedle Patches Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Vaccine Microneedle Patches Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Vaccine Microneedle Patches Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Vaccine Microneedle Patches Sales Value by Type
  10. 4.3.1 Global Vaccine Microneedle Patches Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Vaccine Microneedle Patches Sales Value by Type (2021-2032)
  12. 4.3.3 Global Vaccine Microneedle Patches Sales Value Share by Type (2021-2032)
5 Vaccine Microneedle Patches Market by Application
  1. 5.1 Vaccine Microneedle Patches Application Introduction
  2. 5.1.1 COVID-19 Vaccine
  3. 5.1.2 Enterovirus 71 Vaccine
  4. 5.1.3 Other Vaccines
  5. 5.2 Global Vaccine Microneedle Patches Sales Volume by Application
  6. 5.2.1 Global Vaccine Microneedle Patches Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Vaccine Microneedle Patches Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Vaccine Microneedle Patches Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Vaccine Microneedle Patches Sales Value by Application
  10. 5.3.1 Global Vaccine Microneedle Patches Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Vaccine Microneedle Patches Sales Value by Application (2021-2032)
  12. 5.3.3 Global Vaccine Microneedle Patches Sales Value Share by Application (2021-2032)
6 Vaccine Microneedle Patches Regional Sales and Value Analysis
  1. 6.1 Global Vaccine Microneedle Patches Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Vaccine Microneedle Patches Sales by Region (2021-2032)
  3. 6.2.1 Global Vaccine Microneedle Patches Sales by Region: 2021-2026
  4. 6.2.2 Global Vaccine Microneedle Patches Sales by Region (2027-2032)
  5. 6.3 Global Vaccine Microneedle Patches Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Vaccine Microneedle Patches Sales Value by Region (2021-2032)
  7. 6.4.1 Global Vaccine Microneedle Patches Sales Value by Region: 2021-2026
  8. 6.4.2 Global Vaccine Microneedle Patches Sales Value by Region (2027-2032)
  9. 6.5 Global Vaccine Microneedle Patches Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Vaccine Microneedle Patches Sales Value (2021-2032)
  12. 6.6.2 North America Vaccine Microneedle Patches Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Vaccine Microneedle Patches Sales Value (2021-2032)
  15. 6.7.2 Europe Vaccine Microneedle Patches Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Vaccine Microneedle Patches Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Vaccine Microneedle Patches Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Vaccine Microneedle Patches Sales Value (2021-2032)
  21. 6.9.2 South America Vaccine Microneedle Patches Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Vaccine Microneedle Patches Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Vaccine Microneedle Patches Sales Value Share by Country, 2025 VS 2032
7 Vaccine Microneedle Patches Country-level Sales and Value Analysis
  1. 7.1 Global Vaccine Microneedle Patches Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Vaccine Microneedle Patches Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Vaccine Microneedle Patches Sales by Country (2021-2032)
  4. 7.3.1 Global Vaccine Microneedle Patches Sales by Country (2021-2026)
  5. 7.3.2 Global Vaccine Microneedle Patches Sales by Country (2027-2032)
  6. 7.4 Global Vaccine Microneedle Patches Sales Value by Country (2021-2032)
  7. 7.4.1 Global Vaccine Microneedle Patches Sales Value by Country (2021-2026)
  8. 7.4.2 Global Vaccine Microneedle Patches Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Vaccine Microneedle Patches Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Vaccine Microneedle Patches Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Vaccine Microneedle Patches Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Vaccine Microneedle Patches Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Vaccine Microneedle Patches Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Vaccine Microneedle Patches Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Vaccine Microneedle Patches Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Vaccine Microneedle Patches Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Vaccine Microneedle Patches Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Vaccine Microneedle Patches Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Vaccine Microneedle Patches Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Vaccine Microneedle Patches Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Vaccine Microneedle Patches Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Vaccine Microneedle Patches Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Vaccine Microneedle Patches Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Vaccine Microneedle Patches Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Vaccine Microneedle Patches Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Vaccine Microneedle Patches Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Vaccine Microneedle Patches Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Vaccine Microneedle Patches Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Vaccine Microneedle Patches Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Vaccine Microneedle Patches Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Vaccine Microneedle Patches Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Vaccine Microneedle Patches Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Vaccine Microneedle Patches Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Vaccine Microneedle Patches Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Vaccine Microneedle Patches Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Vaccine Microneedle Patches Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Vaccine Microneedle Patches Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Vaccine Microneedle Patches Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Vaccine Microneedle Patches Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Vaccine Microneedle Patches Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Vaccine Microneedle Patches Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Vaccine Microneedle Patches Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Vaccine Microneedle Patches Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Vaccine Microneedle Patches Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Vaccine Microneedle Patches Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Vaccine Microneedle Patches Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Vaccine Microneedle Patches Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Vaccine Microneedle Patches Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Vaccine Microneedle Patches Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Vaccine Microneedle Patches Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Vaccine Microneedle Patches Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Vaccine Microneedle Patches Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Vaccine Microneedle Patches Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Vaccine Microneedle Patches Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Vaccine Microneedle Patches Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Vaccine Microneedle Patches Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Vaccine Microneedle Patches Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Vaccine Microneedle Patches Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Vaccine Microneedle Patches Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Vaccine Microneedle Patches Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Vaccine Microneedle Patches Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Vaccine Microneedle Patches Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Vaccine Microneedle Patches Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Vaccine Microneedle Patches Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Vaccine Microneedle Patches Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Vaccine Microneedle Patches Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Vaccine Microneedle Patches Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Vaccine Microneedle Patches Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Vaccine Microneedle Patches Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Vaccine Microneedle Patches Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Vaccine Microneedle Patches Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Vaccine Microneedle Patches Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Vaccine Microneedle Patches Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Vaccine Microneedle Patches Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Vaccine Microneedle Patches Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Vaccine Microneedle Patches Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Vaccine Microneedle Patches Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Vaccine Microneedle Patches Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Vaccine Microneedle Patches Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Vaccine Microneedle Patches Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Vaccine Microneedle Patches Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Vaccine Microneedle Patches Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Vaccine Microneedle Patches Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Vaccine Microneedle Patches Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Vaccine Microneedle Patches Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Vaccine Microneedle Patches Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Vaccine Microneedle Patches Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Vaccine Microneedle Patches Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Vaccine Microneedle Patches Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Vaccine Microneedle Patches Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Vaccine Microneedle Patches Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Vaccine Microneedle Patches Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 CosMED Pharmaceutical
  2. 8.1.1 CosMED Pharmaceutical Company Information
  3. 8.1.2 CosMED Pharmaceutical Business Overview
  4. 8.1.3 CosMED Pharmaceutical Vaccine Microneedle Patches Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 CosMED Pharmaceutical Vaccine Microneedle Patches Product Portfolio
  6. 8.1.5 CosMED Pharmaceutical Recent Developments
  7. 8.2 Micron Biomedical
  8. 8.2.1 Micron Biomedical Company Information
  9. 8.2.2 Micron Biomedical Business Overview
  10. 8.2.3 Micron Biomedical Vaccine Microneedle Patches Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Micron Biomedical Vaccine Microneedle Patches Product Portfolio
  12. 8.2.5 Micron Biomedical Recent Developments
  13. 8.3 Raphas
  14. 8.3.1 Raphas Company Information
  15. 8.3.2 Raphas Business Overview
  16. 8.3.3 Raphas Vaccine Microneedle Patches Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Raphas Vaccine Microneedle Patches Product Portfolio
  18. 8.3.5 Raphas Recent Developments
  19. 8.4 VaxessTechnologies
  20. 8.4.1 VaxessTechnologies Company Information
  21. 8.4.2 VaxessTechnologies Business Overview
  22. 8.4.3 VaxessTechnologies Vaccine Microneedle Patches Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 VaxessTechnologies Vaccine Microneedle Patches Product Portfolio
  24. 8.4.5 VaxessTechnologies Recent Developments
  25. 8.5 Shenzhen Qinglan Biotechnology
  26. 8.5.1 Shenzhen Qinglan Biotechnology Company Information
  27. 8.5.2 Shenzhen Qinglan Biotechnology Business Overview
  28. 8.5.3 Shenzhen Qinglan Biotechnology Vaccine Microneedle Patches Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Shenzhen Qinglan Biotechnology Vaccine Microneedle Patches Product Portfolio
  30. 8.5.5 Shenzhen Qinglan Biotechnology Recent Developments
  31. 8.6 WCC Biomedical
  32. 8.6.1 WCC Biomedical Company Information
  33. 8.6.2 WCC Biomedical Business Overview
  34. 8.6.3 WCC Biomedical Vaccine Microneedle Patches Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 WCC Biomedical Vaccine Microneedle Patches Product Portfolio
  36. 8.6.5 WCC Biomedical Recent Developments
  37. 8.7 Zhuhai Youwe Biotechnology
  38. 8.7.1 Zhuhai Youwe Biotechnology Company Information
  39. 8.7.2 Zhuhai Youwe Biotechnology Business Overview
  40. 8.7.3 Zhuhai Youwe Biotechnology Vaccine Microneedle Patches Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Zhuhai Youwe Biotechnology Vaccine Microneedle Patches Product Portfolio
  42. 8.7.5 Zhuhai Youwe Biotechnology Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Vaccine Microneedle Patches Value Chain Analysis
  2. 9.1.1 Vaccine Microneedle Patches Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Vaccine Microneedle Patches Sales Mode & Process
  6. 9.2 Vaccine Microneedle Patches Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Vaccine Microneedle Patches Distributors
  9. 9.2.3 Vaccine Microneedle Patches Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst